Mohamed Benabed

Mohamed Benabed has extensive experience in the field of clinical trials, working in various roles at companies such as Alentis Therapeutics, Novartis Institutes for BioMedical Research, and Medday Pharmaceuticals. With a background in molecular pharmacology and biological sciences, Mohamed has worked in therapy areas such as neurology, cardiology, and ophthalmology. Known for their expertise in managing Phase II, III, and IV trials, Mohamed has successfully led clinical trial teams and handled regulatory activities with precision and professionalism. Additionally, Mohamed has a degree in Key account management from ESSEC Business School, adding to their diverse skill set in the field of clinical research.